Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-04-01
2008-04-01
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C119S231000, C514S012200, C514S013800, C514S015800, C514S021800, C530S324000, C530S326000, C530S328000, C530S857000
Reexamination Certificate
active
07351693
ABSTRACT:
The invention relates to anti-microbial and immunostimulatory molecules of the cathelicidin family derived from fish. The invention provides a novel cathelicidin molecule, fragments, derivatives and uses thereof, and nucleic acids encoding the same.
REFERENCES:
patent: 6172185 (2001-01-01), Hancock
patent: 2007/0020624 (2007-01-01), Rubenfield et al.
patent: 0 665 239 (1995-08-01), None
patent: 01/12668 (2001-02-01), None
Chen, J., et al., “Development of Protegrins for the Treatment and Prevention of Oral Mucositis: Structure-Activity Relationships of Synthetic Protegrin Analogues,” Biopolymers (Peptide Science) 55: 88-98 (2000).
Larrick, J.W., et al., “A Novel Granulocyte-Derived Peptide with Lipopolysaccharide-Neutralizing Acitivity,” Journal of Immunology, 152: 231-241, (1994).
Niyonsaba, F., et al, “Evaluation of the effects of peptide antibiotics human β-defensins-1/-2 and LL-37 on histamine release and prostaglandin D2production from mast cells,” European Journal of Immunology, 31: 1066-1075 (2001).
Lillard, JR., J.W., et al., “Mechanisms for induction of acquired host immunity by neutrophil peptide defensins,” Proc. Natl. Acad. Sci., USA, 96: 651-656 (1999).
Gallo, R.L., et al., “Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds,” Proc. Natl. Acad. Sci. USA, 91: 11035-11039 (1994).
Zhang, G., et al., “Porcine antimicrobial peptides: New prospects for ancient molecules of host defense,” Vet. Res. 31: 277-296 (2000).
Gennaro, R., et al., “Structural Features and Biological Activites of the Cathelicidin-Derived Antimicrobial Peptides,” Biopolymers 55:31-49 (2000).
Frank, R.W., et al., “Amino Acid Sequences of Two Proline-rich Bactenecins,” The Journal of Biological Chemistry, 265: 18871-18874 (1990).
Harwig, S.S.L., et al., “Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes,” FEBS Letters 362: 65-69 (1995).
Gennaro, R., et al., “Biological characterization of a novel mammalian antimicrobial peptide,” Biochimica et Biophysica Acta, 1425: 361-368 (1998).
Gennaro, R., et al., “Purification, Composition, and Activity of Two Bactenecins, Antibacterial Peptides of Bovine Neutrophils,” Infection and Immunity, 57: 3142-3146, (1989).
Niyonsaba, F., et al. “Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL37 on histamine release and prostaglandin D2production from mast cells.” European Journal of Immunology, vol. 31. 2001. pp. 1066-1075.
Risso, A. “Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity.” Journal of Leukocyte Biology, vol. 68. Dec. 2000. pp. 785-792.
Yang, D., et al. “Participation of mammalian defensins and cathelicidins in antimicrobial immunity: receptors and activities of human defensins and cathelicidin.” Journal of Leukocyte Biology, vol. 69. May 2001. pp. 691-697.
Chen, J., et al. “Development of Protegrins for the Treatment of Precention of Oral Mucositis: Structure-Activity Relationship of Synthetic Protegrin Analogues.” Biopolymers (Peptide Science) vol. 55. Jul. 28, 2000. pp. 88-98.
Larrick, J.W., et al. “A Novel Granulocyte-Derived Peptide with Lipopolysaccharide-Neutralizing Activity.” Journal of Immunology, vol. 152. American Association of Immunologists. Oct. 4, 1994. pp. 231-240.
Lillard, JR., J.W., et al. “Mechanisms for induction of acquired host immunity by neutrophil peptide defensins.” Proc. Natl. Acad. Sci., vol. 96. 1999. pp. 651-656.
Gallo, R., et al. “Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.” Proc. Natl. Acad. Sci., vol. 91. Nov. 1994. pp. 11035-11039.
Zhang, G., et al. “Procine antimicrobial peptides: New prospects for ancient molecules of host defense.” Vet. Res., vol. 31. 2000. pp. 277-296.
Gennaro, R., et al. “Structural Features and Biological Activities of the Cathelicidin-Derived Antimicrobial Peptides.” Biopolymers (Peptide Science), vol. 55. 2000. pp. 31-49.
Frank, R.W., et al. “Amino Acid Sequences of Two Proline-rich Bactenecins.” Journal of Biological Chemistry, vol. 265, No. 31. American Society for Biochemistry and Molecular Biology, Enc. Nov. 5, 1990. pp. 18871-18874.
Harwig, S.S.L., et al. “Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes.” FEBS Letters 362: 65-69 (1995).
Gennaro, R., et al. “Biological characterization of a novel mammalian antimicrobial peptide.” Biochimica et Biophysica Acta, vol. 1425. Aug. 4, 1998. pp. 361-368.
Gennaro, R., et al. “Purification, Composition, and Activity of Two Bactenecins, Antibacterial Peptides of Bovine Neutrophils.” Infection and Immunity, vol. 57, No. 10. American Society for Microbiology. Oct. 1989. pp. 3142-3146.
EMBL Online! SL1-0434 Atlantic Salmon liver Salmo salar cDNA clone SL1-0434, mRNA sequence, Oct. 4, 2001. Douglas, S.E., et al. “Expressed sequence tags. A snapshot of the fish genome.” Database acession No. BG935125.
EMBL Online! cDNA library Salmo salar cDNA clone MEN-1087, Feb. 3, 2001.
Davey, G.C., et al. “A survey of genes in the Atlantic salmon (Salmo salar) as identified by expressed sequence tags.” GENE, vol. 263. Elsevier Science Publishers: Amsterdam, Netherlands. Jan. 2001. pp. 121-130.
Shinnar, A.E., et al. Antimicrobial peptides from hagfish: Ancient member of cathelicidin gene family contains bromotryptophan. FASEB Journal, vol. 13, No. 7. Apr. 23, 1999. p. A1395.
Basanez, G., et al. “Interaction of hagfish cathelicidin antimicrobial peptides with model lipid membranes.” FEBS Letters, vol. 532, No. 1-2. Elsevier Science Publishers: Amsterdam, Netherlands. Dec. 4, 2002. pp. 115-120.
Tossi, A., al al. “Design of synthetic antimicrobial peptides based on sequence analogy and amphipathicity.” European Journal of Biochemistry, vol. 250, No. 2. Berlin, Germany. Dec. 1997. pp. 549-558.
Tossi, A., et al. “Amphipathic Alpha-Helical Antimicrobial Peptides.” Biopolymers (Peptide Science), vol. 55, No. 1. 2000. pp. 4-30.
Epand, R.M., et al. “Diversity of antimicrobial peptides and their mechanisms of action.” Biochimica et Biophysica Acta, vol. 1462, No. 1-2. Elsevier Science Publishers: Amsterdam, Netherlands. Dec. 15, 1999. pp. 11-28.
Gallo, R., et al. “Antimicrobial peptides: An Emerging Concept in Cutaneous Biology.” Journal of Investigative Dermatology, vol. 111, No. 5. Society for Investigative Dermatology, USA. Nov. 1998. pp. 739-743.
Zanetti, M., et al. “Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain.” FEBS Letters, vol. 374, No. 1. Amsterdam, Netherlands. Oct. 23, 1995. pp. 1-5.
Pleguezuelos Olga
Secombes Christopher John
Dann Dorfman Herrell & Skillman P.C.
Rigaut Kathleen D.
Russel Jeffrey Edwin
University Court of the University of Aberdeen
LandOfFree
Peptides and nucleic acids of the cathelicidin family,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and nucleic acids of the cathelicidin family,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and nucleic acids of the cathelicidin family,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2760344